FDA Device Intelligence
HomeREXXAM CO., LTD. › Rexxam

Rexxam

REXXAM CO., LTD. · Model WAM-5500 · UDI-DI 04540008310320

HKO
10
510(k) clearances
173
Adverse events
5
Recalls
76
Facilities

Description

This device aims to objectively measure the refractive power of the eye by using the light that is projected to and reflected from the eyeground. It also aims to measure the radius of corneal curvature by using the light that is projected to and reflected from the cornea.

Recalls

DateFirmReason
2026-02-18Baxter Healthcare CorporationDisplay screen may unintentionally flicker due to a software issue. Exposure to flickering lights may induce photosensitive seizure activity in susceptible individuals.
2020-08-06Carl Zeiss Meditec AGDue to the incorrect DC/DC converter being assembled onto the communication board. As a result the effectiveness of the communication board cannot be guaranteed in that the safety
2017-12-20Nidek Inc.There is possibly a difference between the measured dioptric value of the subjective measurement mode and the objective measurement mode on ARK-1s.
2015-06-15Nidek IncSoftware bug was found where there was no difference in Total and Corneal high-order aberrations, but differences were found in Internal high-order aberrations.
2012-12-05Canon Inc.Canon Inc. had received 17 claims from our foreign sales companies between October to November 2012 that measurement value of RK-F2s refractive power (SPH value) sometimes indicate

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.